Introduction
Helicobacter species colonise the human gastrointestinal and hepatobiliary tract, usually resulting in chronic infection coupled with an inflammatory host response. This colonisation is associated with a variety of gastrointestinal and hepatobiliary diseases. 1 The enterohepatic helicobacters such as Helicobacter hepaticus and H. bilis, first recognised in laboratory rodents, have been considered a component of the normal flora. H. hepaticus colonises the lower gastrointestinal tract, including the caecum, colon and hepatobiliary system of mice and causes chronic active hepatitis and typhlocolitis in immunocompetent mice and can lead to liver carcinoma in male mice of susceptible strains. [2] [3] [4] [5] H. bilis was also identified in inbred mice with chronic hepatitis. 6 Patients with chronic liver disease have been reported to have significantly higher levels of antibody to H. bilis and H. hepaticus compared to healthy subjects. 7 These urease-producing bacteria may induce stone formation by hydrolysing urea into ammonia that increases the pH and favours precipitation of salts that lead to subsequent stone formation. 8, 9 It has also been demonstrated that cholesterol gallstone-prone C57L/J mice rarely develop gallstones unless they are infected with certain cholelithogenic enterohepatic Helicobacter species. 10 In a previous study, all four urease-positive Helicobacter species (H. hepaticus, H. bilis, H. pylori and H. mustelae) were shown to be capable of precipitating calcium. 11 This suggests that urease-positive Helicobacter species that are able to survive in or colonise the bile ducts may induce the formation of gallstones, both directly via their urease activity or indirectly via the immune response.
11 H. pylori has also been shown to colonise areas of gastric metaplasia in the gall bladder, producing histological changes similar to those seen in the gastric mucosa. 12 Isolation of H. pylori DNA from gallstones further supports its presence in the gall bladder. 12 Helicobacter species have been detected in patients with biliary tract cancer significantly more frequently than in controls. [13] [14] [15] There are reports that biliary Helicobacter colonisation is frequent in countries with a high incidence of gall bladder carcinoma, the highest incidence rates in this region being reported for women in Delhi, India (21.5/100,000), and in Karachi, Pakistan (13.8/100,000). 16 In a previous study, the incidence of gallstones was determined in cases of carcinoma of the gall bladder. In this series, 93% of patients had gallstones (85% were female, age range: 27-65 years). 17 A recent study in Karachi looked at the frequency of biliary infection associated with cholelithiasis. Results showed that a total of 36% had bile culture positive for Escherichia coli (17%) Klebsiella (9%), Pseudomonas (6%), Staphylococcus aureus (2%), Salmonella (1%) and Bacteroides fragilis (1%). 18 However, H. pylori also has a high prevalence in the local population. 19 The prevalence of H. pylori in bile and the gall bladder has not been examined previously in patients with gall bladder disorders in Pakistan. Therefore, this study aims to 
Materials and Methods
One hundred and forty-four patients undergoing cholecystectomy were enrolled on the study between January Immunohistochemistry staining for H. pylori was performed using streptavidin peroxidase (SP). Anti-H. pylori antibody (Dako) was diluted (1 in 10), and phosphatebuffered saline (PBS) was used as blank control, normal blood serum as a negative control, and sections of gastric mucosa containing H. pylori as the positive control.
DNA extraction
Extraction of DNA from bile and gall bladder tissue was performed as described previously. 20 Briefly, 450 µL bile was diluted with an equal volume of PBS (pH 8) and centrifuged at 14 000 xg for 20 min. Extraction of DNA from gall bladder tissue was performed as described previously. 21 Gall bladder tissue (50 mg) was homogenised to uniformity in 400 µL sterile water and centrifuged at 8000 xg for 10 min. Then, 400 µL lysis buffer (100 mmol/L NaCl, 10 mmol/L Tris-HCl [pH 8], 25 mmol/L EDTA, 0.5% SDS) and 10 µL proteinase K (10 mg/mL) were added. Incubation was carried out at 56˚C for 20 h, and proteinase K was inactivated by boiling for 10 min. This was followed by phenol-chloroform extraction and ethanol precipitation. The resulting pellet was allowed to dissolve in 35 µL TE buffer (10 mmol/L Tris-HCl [pH 7.4] and 0.1 mmol/L EDTA [pH 8]) for 20 h at 37˚C. Samples were stored at -20˚C before PCR amplification was performed. DNA content and purity was determined by measuring absorbance at 260 nm and 280 nm using a spectrophotometer (Beckman DU-600, USA).
PCR amplification
Samples were amplified by Helicobacter genus-specific 16S rRNA primers. The forward (C97) and reverse (C98) primers amplified a product of approximately 400 bp. 21 Samples generating a positive result were subsequently analysed with eight different sets of primers. Two specific primer sets were used to detect H. bilis and H. hepaticus 16S rRNA sequences previously described. 22 The other six specific primers used were to look for the glmM and vacA alleles (e.g., s1a, s1b, s1m1 and s1m2, and cagA genes), 23, 24 which encode potential virulence factors in H. pylori. Nucleotide primer sequences and PCR conditions are shown in Table 1 . The amplified products were analysed on 2% (w/v) agarose gel stained with ethidium bromide and observed under short-wavelength ultraviolet light.
Sequence analyses
Amplicons were purified from the agarose gel by a DNA extraction kit (Roche, Indianapolis, Indiana, USA). Three amplicons from the gall bladder were sequenced to verify that they were H. pylori 16S rRNA and glmM genes. Sequence analysis was performed (Macrogen, Seoul, South Korea) using primers for 16S rRNA and glmM genes. Sequence comparison was carried out using the BLAST program and the GenBank database. Results of PCR amplification of 16S rDNA, glmM, cagA and vacA in the different groups are shown in Table 2 . None of the samples showed PCR positivity for either H. bilis or H. hepaticus. H. pylori 16S rDNA PCR and IHC were both positive in 24% (21/89) of study cases compared to 9% (5/55) of the control group (P=0.03; Table 2 ). The glmM gene PCR and IHC were also both positive in 24% (21/89) of study group cases compared to 9% (5/55) of the control group (P=0.03; Table 2 ).
Statistical analysis
There was significant correlation between PCR for H. pylori 16S rDNA and IHC, with 20/23 in the study group positive by both techniques (κ=85%, P<0.001). Both PCR for 16S rDNA and IHC were positive in 21(24%) cases of cholecystitis associated with gallstones, in no cases of gall bladder carcinoma without cholelithiasis (P<0.001) and in 5/6 (83%) cases of gall bladder carcinoma with cholelithiasis (P=0.005; Tables 3a-c).
Three 16S rRNA and glmM gene PCR products were selected at random for sequencing. The 16S rRNA gene sequences HM596599-HM596601 and glmM gene sequences GQ334379-GQ334382 produced significant alignments with NC 008086. 
Discussion
This study demonstrated that H. pylori DNA was positive in 24% in a study group comprising patients undergoing cholecystectomy for cholelithiasis associated with chronic cholecystitis by PCR and IHC (P=0.03 and P=0.03, respectively). However, it was not demonstrated in gall bladder carcinoma without stones or in cases of gall bladder polyps.
It is interesting that H&E, Giemsa and Warthin-Starry stains were inconclusive while IHC results correlated with PCR findings. This could be explained by the absence of areas of intestinal metaplasia in the gall bladder mucosa, as described previously. 12 It is also known that after treatment for chronic active gastritis, H pylori can change shape and decrease in number, making identification and differentiation from extracellular debris or mucin difficult. In such cases, IHC improves the rate of identification, even when histological examination and cultures were negative. 25, 26 This study did not attempt to culture H. pylori from the bile or the gall bladder as poor culture yield is known to follow storage of these specimens. Direct culture of clinical samples would increase the probability of in vitro H. pylori isolation and identification.
In a recent study, Chen et al. demonstrated H. pylori in the gall bladder of patients with chronic cholecystitis, 27 in whom the incidence of bile reflux was significantly higher. H. pylorilike bacteria were found in 14% of gall bladders using the Warthin-Starry silver stain and in 7% using IHC. 27 They also demonstrated that in patients with cholecystitis associated with cholelithiasis there was a high incidence of gastric H. pylori infection. Similar results were reported by Caldwell et al. who studied H. pylori infection rate and gastritis in patients with chronic calculus cholecystitis before and after cholecystectomy and found that the duodenogastric reflux increased after cholecystectomy. 28 Bile regurgitation appears to play a role in selecting H. pylori that are resistant to bile salts, and, while aggravating any injury to the gastric mucosa, they are able to enter the gall bladder from the duodenum.
14 Also, low bile pH has been shown to permit survival of H. pylori. 29 Biliary infection, cystic and common bile duct obstruction and acute cholecystitis have been shown to decrease bile pH, therefore increasing the likelihood of infection with Helicobacter species in these diseases. 30, 31 The implications of these studies are that H. pylori can resist the effect of bile salts and survive under basic conditions. It is known that increased incidence of hepatobiliary disease is associated with chronic carriage of Salmonella typhi and also a high risk of hepatobiliary cancer. 32 Whether or not H. pylori has a similar relationship in patients with chronic cholecystitis can only be ascertained by a large prospective study of hepatobiliary disease using appropriate tests for H. pylori diagnosis. Thus, currently it is only possible to conclude that H. pylori is present in the bile and gall bladder of Pakistani patients with chronic cholecystitis associated with cholelithiasis and gall bladder carcinoma associated with cholelithiasis, and is involved in the immunopathogenesis of gall bladder disorders in some cases.
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